Home > Press > NVE Notified of Grant of Two Patents Related to Laboratory-on-a-Chip Technology
Abstract:
NVE Corporation (Nasdaq:NVEC) announced today that it has been notified by the U.S. Patent and Trademark Office of the expected grant of two patents relating to "laboratory-on-a-chip" technology.
The company has been notified that patent number 7,235,969, titled "Thin-Film Structure Magnetizable Bead Detector," will issue today and that patent number 7,238,539, titled "Magnetizable Bead Detector," will issue July 3, 2007.
In proposed laboratory-on-a-chip systems, magnetic biological marker nano-beads adhere to an immobilization surface when a targeted biological agent is present. Spintronic biosensors detect magnetic perturbations from the nano-beads to detect and quantify the presence of very low levels of biological or chemical materials.
The grants will bring NVE's U.S. patent total to 44. The company has more than 100 patents worldwide issued, pending, or licensed from others. Links to the new patent and NVE's other U.S. patents can be found at the "About NVE" section of the company's Website ( http://www.nve.com ).
####
About NVE Corporation
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that many experts believe represents the next generation of microelectronics. NVE licenses its MRAM intellectual property and sells spintronic products, including sensors and couplers, to revolutionize data sensing and transmission.
The NVE Corporation logo is available at
http://www.primenewswire.com/newsroom/prs/?pkgid=3120
Statements used in this press release that relate to future plans, events, or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as uncertainties relating to the grant of patents in the future, risks in the enforcement of our patents, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K and other reports filed with the SEC.
For more information, please click here
Contacts:
NVE Corporation
Curt A. Reynders
Chief Financial Officer
(952) 829-9217
Copyright © PrimeNewswire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||